A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

Clinical trial NCT02255513 · COMPLETED

Trial details

NCT number: NCT02255513
Sponsor: Ironshore Pharmaceuticals and Development, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2014-05-01
Primary completion: 2014-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.